Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Prevalence
69%
T Cell
69%
CD4
43%
Disease Specific Survival
34%
Transcriptome
34%
Gene Signature
34%
Subtyping
34%
Insulin Resistance
34%
Immune Checkpoints
34%
Epigenetics
34%
Polygenic Score
34%
Impaired Glucose Tolerance
34%
Genetic Risk
34%
HLA-DRA
34%
HLA-DR
34%
Galectin
34%
ARG1
34%
Sex Differences
34%
Tumor-Infiltrating Lymphocytes
33%
PD-L1
26%
Lysine
26%
Upregulation
26%
Histone H3
26%
TIGIT
26%
CD33
21%
CD8
18%
Genetic Screening
17%
Promoter Region
17%
Messenger RNA
17%
CD160
17%
DNA Hypomethylation
13%
Volume
13%
Downregulation
9%
CTLA-4
8%
Epigenetic Modification
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Real-Time Polymerase Chain Reaction
8%
Chromatin Immunoprecipitation
8%
Bisulfite Sequencing
8%
CD244
8%
PRDM1
8%
Genome-Wide Association Study
7%
Immunosurveillance
6%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
72%
Biobank
69%
Evaluation Index
34%
Insulin Resistance
34%
Genetic Risk
34%
Risk Index
34%
Polygenic Risk Score
34%
Pre-diabetes (pre-DM)
34%
Precision Medicine
34%
Middle Eastern
34%
Cancer Immunotherapy
34%
HLA-A*0201
34%
Immunogenic Epitopes
34%
Lactate Dehydrogenase C
34%
Exhaustion Marker
34%
Tumor-infiltrating T Cells
34%
Arginase-1 (Arg-1)
34%
Mild Age-related Diabetes
28%
TOX2
26%
Severe Insulin-deficient Diabetes
17%
Mild Obesity-related Diabetes
17%
Metabolic-associated Fatty Liver Disease (MAFLD)
17%
Chronic Kidney Disease
17%
Maturity-onset Diabetes of the Young
17%
Severe Insulin-resistant Diabetes
17%
Histone H3 Lysine 4
17%
Tumor-associated Myeloid Cells
17%
Qatar Biobank
16%
TIGIT
14%
Prognosis Score
13%
T Cells
12%
Young Individuals
11%
High Risk
11%
Actual Age
11%
Diabetes Subtypes
11%
DNA Hypomethylation
11%
Suppressive Molecules
11%
CD160
9%
T Cell Activation
9%
Peptide Pools
9%
Breast Cancer Cells
9%
Real-time Reverse Transcriptase PCR
8%
Differentially Expressed Pathways
8%
Immune Cell Recruitment
8%
Pro-tumor
8%
Myeloid Lineage
8%
Hypoxia-related Genes
8%
Insulin
8%
Genome-wide Association Study
7%
Area under the Curve
7%
Immunology and Microbiology
T Cell
100%
Insulin
44%
Prevalence
43%
Tumor-Infiltrating Lymphocytes
43%
CD4
43%
Disease Specific Survival
40%
Peptides
37%
Insulin Resistance
34%
Cancer Immunotherapy
34%
Epitope
34%
CD33
34%
Gene Expression
34%
Transcriptome
34%
Myeloid
34%
Epigenetics
34%
Ecalectin
34%
T-Helper Cell
34%
Upregulation
26%
Programmed Death-Ligand 1
26%
CD8
22%
Volume
21%
Cancer Cell
17%
Promoter Region
17%
T Cell Activation
15%
Downregulation
13%
Immunocompetent Cell
12%
Inflammation Response
12%
Transcriptomics
12%
Secretion (Process)
8%
In Vitro
8%
Sex Differences
8%
Immunotherapy
8%
Cancer Testis Antigen
8%
Epigenetic Modification
8%
CTLA-4
8%
Real-Time Polymerase Chain Reaction
8%
Chromatin Immunoprecipitation
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Angiogenesis
6%
Cell Population
6%
Cytotoxic T Cell
6%
Regulatory T Cell
6%
Lineages
5%
Mortality Rate
5%